Nevirapine - NEVIRAPINE
Navigation: NDC > Supplier starting with: S > SETON PHARMACEUTICALS| Field | Value |
|---|---|
| NDC Code: | 13925-500 |
| Proprietary Name: | Nevirapine |
| Suffix: | |
| Non-Proprietary Name: | NEVIRAPINE |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 21-05-2012 |
| End of Marketing: | 30-04-2014 |
| Category Name: | ANDA |
| Application Number: | ANDA203176 |
| Labeler: | SETON PHARMACEUTICALS |
| Substance Name: | NEVIRAPINE |
| Active Numerator Strength: | 200 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |